Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITCH intronic transcript 1 (ITCH-IT1) is a non-coding RNA transcript derived from the intronic regions of the ITCH gene, likely classified as a long non-coding RNA (lncRNA)[1][2]. Non-coding transcripts from the ITCH locus may regulate expression of the ITCH gene itself or act through competing endogenous RNA mechanisms (e.g., miRNA sponging), especially in the context of related circRNAs (e.g., circ-ITCH)[2][6]. Although non-coding RNAs from the ITCH locus (notably circ-ITCH) have documented relevance in cancer and immune signaling, ITCH-IT1 itself is not presently recognized as a therapeutic target, druggable protein, or validated biomarker[1][2][3][6]. Its biological functions remain largely uncharacterized, though, by analogy to other intronic non-coding RNAs, it may have regulatory or epigenetic effects[3][6].
Not applicable. Mechanistic data relate to gene regulation or miRNA sponging (especially for circ-ITCH) but not to direct pharmacological intervention on ITCH-IT1 itself
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITCH intronic transcript 1 (ITCH-IT1).